日本の医薬品原薬(API)市場規模、シェア、動向、予測医薬品タイプ、メーカータイプ、合成タイプ、治療用途、地域別、2025-2033年

日本の医薬品原薬(API)市場規模、シェア、動向、予測医薬品タイプ、メーカータイプ、合成タイプ、治療用途、地域別、2025-2033年

Report Format: PDF+Excel | Report ID: SR112025A27209

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Japan Active Pharmaceutical Ingredients (API) Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   Japan Active Pharmaceutical Ingredients (API) Market Landscape
    5.1    Historical and Current Market Trends (2019-2024)
    5.2    Market Forecast (2025-2033)
6   Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Drug Type
    6.1     Innovative Active Pharmaceutical Ingredients (API)
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2019-2024)
        6.1.3 Market Forecast (2025-2033)
    6.2    Generic Active Pharmaceutical Ingredients (API)
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2019-2024)
        6.2.3 Market Forecast (2025-2033)
7   Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Type of Manufacturer
    7.1    Captive Manufacturers
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2019-2024)
        7.1.3 Market Forecast (2025-2033)
    7.2    Merchant API Manufacturers
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2019-2024)
        7.2.3 Market Segmentation
           7.2.3.1 Innovative Merchant API Manufacturers
           7.2.3.2 Generic Merchant API Manufacturers
        7.2.4 Market Forecast (2025-2033)
8   Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Type of Synthesis 
    8.1    Synthetic Active Pharmaceutical Ingredients (API)
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2019-2024)
        8.1.3 Market Segmentation
           8.1.3.1 Type
              8.1.3.1.1 Innovative Synthetic APIs
              8.1.3.1.2 Generic Synthetic APIs
        8.1.4 Market Forecast (2025-2033)
    8.2    Biotech Active Pharmaceutical Ingredients (API)
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2019-2024)
            8.2.3 Market Segmentation
                8.2.3.1 Type
                   8.2.3.1.1 Innovative Biotech APIs
                   8.2.3.1.2 Biosimilars
                8.2.3.2 Product
                   8.2.3.2.1 Monoclonal Antibodies
                   8.2.3.2.2 Vaccines
                   8.2.3.2.3 Cytokines
                   8.2.3.2.4 Fusion Proteins
                   8.2.3.2.5 Therapeutic Enzymes
                   8.2.3.2.6 Blood Factors
                8.2.3.3 Expression System
                   8.2.3.3.1 Mammalian Expression Systems
                   8.2.3.3.2 Microbial Expression Systems
                   8.2.3.3.3 Yeast Expression Systems
                   8.2.3.3.4 Transgenic Animal Systems
                   8.2.3.3.5 Others
        8.2.4 Market Forecast (2025-2033)
9   Japan Active Pharmaceutical Ingredients (API) Market - Breakup by Therapeutic Application
    9.1    Oncology
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2019-2024)
        9.1.3 Market Forecast (2025-2033)
    9.2    Cardiovascular and Respiratory
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2019-2024)
        9.2.3 Market Forecast (2025-2033)
    9.3    Diabetes 
        9.3.1 Overview
        9.3.2 Historical and Current Market Trends (2019-2024)
        9.3.3 Market Forecast (2025-2033)
    9.4    Central Nervous System Disorders
        9.4.1 Overview
        9.4.2 Historical and Current Market Trends (2019-2024)
        9.4.3 Market Forecast (2025-2033)
    9.5    Neurological Disorders
        9.5.1 Overview
        9.5.2 Historical and Current Market Trends (2019-2024)
        9.5.3 Market Forecast (2025-2033)
    9.6    Others
        9.6.1 Historical and Current Market Trends (2019-2024)
        9.6.2 Market Forecast (2025-2033)
10  Japan Active Pharmaceutical Ingredients (API) Market – Breakup by Region
    10.1    Kanto Region
        10.1.1 Overview
        10.1.2 Historical and Current Market Trends (2019-2024)
        10.1.3 Market Breakup by Drug Type
        10.1.4 Market Breakup by Type of Manufacturer
        10.1.5 Market Breakup by Type of Synthesis
        10.1.6 Market Breakup by Therapeutic Application
        10.1.7 Key Players
        10.1.8 Market Forecast (2025-2033)
    10.2    Kansai/Kinki Region
        10.2.1 Overview
        10.2.2 Historical and Current Market Trends (2019-2024)
        10.2.3 Market Breakup by Drug Type
        10.2.4 Market Breakup by Type of Manufacturer
        10.2.5 Market Breakup by Type of Synthesis
        10.2.6 Market Breakup by Therapeutic Application
        10.2.7 Key Players
        10.2.8 Market Forecast (2025-2033)
    10.3    Central/ Chubu Region
        10.3.1 Overview
        10.3.2 Historical and Current Market Trends (2019-2024)
        10.3.3 Market Breakup by Drug Type
        10.3.4 Market Breakup by Type of Manufacturer
        10.3.5 Market Breakup by Type of Synthesis
        10.3.6 Market Breakup by Therapeutic Application
        10.3.7 Key Players
        10.3.8 Market Forecast (2025-2033)
    10.4    Kyushu-Okinawa Region
        10.4.1 Overview
        10.4.2 Historical and Current Market Trends (2019-2024)
        10.4.3 Market Breakup by Drug Type
        10.4.4 Market Breakup by Type of Manufacturer
        10.4.5 Market Breakup by Type of Synthesis
        10.4.6 Market Breakup by Therapeutic Application
        10.4.7 Key Players
        10.4.8 Market Forecast (2025-2033)
    10.5    Tohoku Region
        10.5.1 Overview
        10.5.2 Historical and Current Market Trends (2019-2024)
        10.5.3 Market Breakup by Drug Type
        10.5.4 Market Breakup by Type of Manufacturer
        10.5.5 Market Breakup by Type of Synthesis
        10.5.6 Market Breakup by Therapeutic Application
        10.5.7 Key Players
        10.5.8 Market Forecast (2025-2033)
    10.6    Chugoku Region
        10.6.1 Overview
        10.6.2 Historical and Current Market Trends (2019-2024)
        10.6.3 Market Breakup by Drug Type
        10.6.4 Market Breakup by Type of Manufacturer
        10.6.5 Market Breakup by Type of Synthesis
        10.6.6 Market Breakup by Therapeutic Application
        10.6.7 Key Players
        10.6.8 Market Forecast (2025-2033)
    10.7    Hokkaido Region
        10.7.1 Overview
        10.7.2 Historical and Current Market Trends (2019-2024)
        10.7.3 Market Breakup by Drug Type
        10.7.4 Market Breakup by Type of Manufacturer
        10.7.5 Market Breakup by Type of Synthesis
        10.7.6 Market Breakup by Therapeutic Application
        10.7.7 Key Players
        10.7.8 Market Forecast (2025-2033)
    10.8    Shikoku Region
        10.8.1 Overview
        10.8.2 Historical and Current Market Trends (2019-2024)
        10.8.3 Market Breakup by Drug Type
        10.8.4 Market Breakup by Type of Manufacturer
        10.8.5 Market Breakup by Type of Synthesis
        10.8.6 Market Breakup by Therapeutic Application
        10.8.7 Key Players
        10.8.8 Market Forecast (2025-2033)
11  Japan Active Pharmaceutical Ingredients (API) Market – Competitive Landscape
    11.1    Overview
    11.2    Market Structure
    11.3    Market Player Positioning
    11.4    Top Winning Strategies
    11.5    Competitive Dashboard
    11.6    Company Evaluation Quadrant
12  Profiles of Key Players
    12.1    Company A 
        12.1.1 Business Overview
        12.1.2 Product Portfolio
        12.1.3 Business Strategies
        12.1.4 SWOT Analysis
        12.1.5 Major News and Events
    12.2    Company B
        12.2.1 Business Overview
        12.2.2 Product Portfolio
        12.2.3 Business Strategies
        12.2.4 SWOT Analysis
        12.2.5 Major News and Events
    12.3    Company C
        12.3.1 Business Overview
        12.3.2 Product Portfolio
        12.3.3 Business Strategies
        12.3.4 SWOT Analysis
        12.3.5 Major News and Events
    12.4    Company D 
        12.4.1 Business Overview
        12.4.2 Product Portfolio
        12.4.3 Business Strategies
        12.4.4 SWOT Analysis
        12.4.5 Major News and Events
    12.5    Company E
        12.5.1 Business Overview
        12.5.2 Product Portfolio
        12.5.3 Business Strategies
        12.5.4 SWOT Analysis
        12.5.5 Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

13  Japan Active Pharmaceutical Ingredients (API) Market - Industry Analysis
    13.1    Drivers, Restraints, and Opportunities
        13.1.1 Overview
        13.1.2 Drivers
        13.1.3 Restraints
        13.1.4 Opportunities
    13.2   Porters Five Forces Analysis
        13.2.1 Overview
        13.2.2 Bargaining Power of Buyers
        13.2.3 Bargaining Power of Suppliers
        13.2.4 Degree of Competition
        13.2.5 Threat of New Entrants
        13.2.6 Threat of Substitutes
    13.3    Value Chain Analysis
14  Appendix

日本の医薬品原薬(API)市場規模、シェア、動向、予測医薬品タイプ、メーカータイプ、合成タイプ、治療用途、地域別、2025-2033年
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials